The cost of all brand-name drugs for epilepsy paid by the Medicare system increased by 277% from 2010 to 2018, according to a new study from a University of Michigan team. During that same time, the amount that Medicare paid for generic drugs for epilepsy decreased by 42%, the team reports in a paper published online in Neurology, the medical...